Antibody with engineered peptide targets bone metastasis

A moderate amount of a peptide-enhanced, biological cancer drug goes a long way in treating breast cancers that metastasize to the bone. A moderate

Related Keywords

Rice University ,Texas ,United States ,Houston ,Baylor College Of Medicine ,Princeton ,American ,Chenfei Yu ,Chanfei Yu ,Chenhang Wang ,Weijie Zhang ,Kuan Lin Wu ,Yuda Chen ,Zhan Xu ,Han Xiao ,Ruchi Gupta ,Xiang Zhang ,Department Of Defense ,Roberta Welch Foundation ,Xiao Research Group ,American Chemical Society ,Cancer Prevention Research Institute Of Texas ,Baker Institute For Public ,Yale School Of Medicine ,Scientists At Rice University ,National Institutes Of Health ,Natural Sciences ,Xiao Research Group Cover ,Xiao Research Group Rice ,Johns Dunn Foundation ,Sue Smith Breast Center At Baylor ,Xiao Research Group Rice University ,Princeton Review ,Baylor College ,Xiao Research ,Zeru Tian ,Yale School ,Norman Hackerman Welch Young Investigator ,Mcnair Scholar ,Sue Smith Breast Center ,Cancer Prevention Research Institute ,National Institutes ,Hamill Innovation Award ,Continuing Studies ,Social Sciences ,Baker Institute ,